SF3B1

There are 38 papers on SF3B1 in aging research: 2 trials and 24 observational studies in people, 3 in animals, 2 in cells, 4 reviews. The newest story, Oct 9, 2026: “Blood stem-cell mutations linked to serious bacterial infections”.

Gene

38 papers study it4 findings

HGNCNCBI GeneTaxon

2 new papers in 30 daysSee all 38 papers on SF3B1

At a glance

The findings reach people, from one lab or study. 3 independent labs in 3 countries.

“however, SF3B1 mutation predicted favourable therapeutic response”
Distinct clinical and genetic characteristics of myelodysplastic syndrome in younger patientsBritish journal of haematology2026doi:10.1111/bjh.70770

None of its findings points the other way.

Mice and humans: a single group. Cells and worms or flies: nothing yet.
  • 3 independent labs in 3 countries
  • Funders: National Heart, Lung, and Blood Institute and others
  • 2 of 4 findings with company ties
  • Human trial2
  • Humans24
  • Animals3
  • Cells2
  • In silico2

Effects

1

Cellular senescence

upin mice1

1 study
  1. SF3B1 induces cellular senescence in mice (B cell-restricted expression of Sf3b1-K700E).

    AnimalsB cell-restricted expression of Sf3b1-K700EB cells

More on Cellular senescence

Associations

3

Therapeutic response to hypomethylating agents

upin humans1

1 study
  1. SF3B1 predicts therapeutic response to hypomethylating agents in humans (patients treated with hypomethylating agents).

    Humanspatients treated with hypomethylating agents

Inflammation

upin humans1

1 study
  1. SF3B1 is associated with inflammation in MDS patients (BMMNC and CD34+ cohorts).

    Humansin MDS patients (BMMNC and CD34+ cohorts)bone marrow

More on Inflammation

Response to BTK inhibition

mixedin humans1

1 study
  1. SF3B1 is associated with response to BTK inhibition in humans (SF3B1-mutated chronic lymphocytic leukemia).

    HumansSF3B1-mutated chronic lymphocytic leukemia

Funding

2 grants since 2022

National Heart, Lung, and Blood Institute$4.1M

Latest

Dec 2025: 0Jan 2026: 3Feb 2026: 1Mar 2026: 3Apr 2026: 2May 2026: 2Jun 2026: 1Jul 2026: 0Aug 2026: 2Sep 2026: 2Oct 2026: 2Nov 2026: 018 papers in 12 months
Nature Communications

Blood stem-cell mutations linked to serious bacterial infections

In an analysis of 889,215 people, clonal blood mutations were associated with serious bacterial infections, with a hazard ratio of 1.22.In an analysis of 889,215 people, clonal blood mutations were associated with serious bacterial infections, with a hazard ratio of 1.22.

Cohort study of 889,215 peopleMechanisms

See all 38 papers on SF3B1